Submitted by Anonymous (not verified) on 19 October 2023 - 15:34
Human medicines European public assessment report (EPAR): Lytgobi, futibatinib, Cholangiocarcinoma, Date of authorisation: 04/07/2023, Revision: 1, Status: Authorised
Source: